Said Nassier Said Alsenani, Rawan Nasser Almaskari, Yusra Abid Shah, Balqees Yousuf Hussain Al Mujaini, Alshifa Khalifa Alsaidi, Maryam Saud Mohammed AlBalushi, Fatema Dawood Mulla Hasan Almualem, Tariq Al-Saadi
{"title":"Neuro-oncology Burden in Developing Countries: A Retrospective Cost-Analysis Study.","authors":"Said Nassier Said Alsenani, Rawan Nasser Almaskari, Yusra Abid Shah, Balqees Yousuf Hussain Al Mujaini, Alshifa Khalifa Alsaidi, Maryam Saud Mohammed AlBalushi, Fatema Dawood Mulla Hasan Almualem, Tariq Al-Saadi","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Brain tumours are a significant economic burden on patients and health systems.</p><p><strong>Objectives: </strong>This research aims to study the cost associated with management of brain tumour and its impact on healthcare.</p><p><strong>Methods and material: </strong>This is a retrospective observational study involving 280 patients with brain tumours at the Neurosurgery Department at Khoula Hospital in Oman. Data on patient demographics, type of brain tumour, diagnosis, treatment, cost of imaging and laboratory investigations, and length of hospital stay were collected from medical records.</p><p><strong>Results: </strong>The average cost of imaging and laboratory investigations was $276,293.33, with imaging accounting for $208,168.7 and laboratory tests accounting for $68,124.63. CT scan was the most expensive imaging investigation, followed by MRI and X-ray. RFT, MDR, and MRSA screening were the most expensive laboratory tests. The most common diagnosis was meningioma (18% of cases). The average length of hospital stay was 16 days.</p><p><strong>Conclusion: </strong>The cost of brain tumour management in Oman is significant. Further research is needed to understand the full economic burden of brain tumour management in Oman, including the costs of surgical and non-surgical interventions.</p>","PeriodicalId":523894,"journal":{"name":"The Gulf journal of oncology","volume":"1 50","pages":"19-27"},"PeriodicalIF":0.0000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Gulf journal of oncology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Brain tumours are a significant economic burden on patients and health systems.
Objectives: This research aims to study the cost associated with management of brain tumour and its impact on healthcare.
Methods and material: This is a retrospective observational study involving 280 patients with brain tumours at the Neurosurgery Department at Khoula Hospital in Oman. Data on patient demographics, type of brain tumour, diagnosis, treatment, cost of imaging and laboratory investigations, and length of hospital stay were collected from medical records.
Results: The average cost of imaging and laboratory investigations was $276,293.33, with imaging accounting for $208,168.7 and laboratory tests accounting for $68,124.63. CT scan was the most expensive imaging investigation, followed by MRI and X-ray. RFT, MDR, and MRSA screening were the most expensive laboratory tests. The most common diagnosis was meningioma (18% of cases). The average length of hospital stay was 16 days.
Conclusion: The cost of brain tumour management in Oman is significant. Further research is needed to understand the full economic burden of brain tumour management in Oman, including the costs of surgical and non-surgical interventions.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
